WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/22/2025ACC: 0001415889-25-014263
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-15.36K
Net shares
Net seller
$145.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
15.36K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−15.36K
Price / share
$9.45
Trade value
$145.19K
% of position
0.9%
5/20/2025
1.78M→1.76M
Total
Net shares
−15.36K
Net value
-$145.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/20/2025 | F · Tax Withholding | −15.36K | $9.45 | $145.19K | 0.9% | 1.78M | 1.76M |
| Total | −15.36K | -$145.19K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned92.57K
Ordinary Shares
IndirectShares owned3.90K
Total
96.47K indirect96.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Ordinary Shares | 3.90K | Indirect |
| Total | 96.47K | 96.47K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported